A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations
Open Access
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 13 (7) , 662-666
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with cautionNeurosurgical Focus, 2010
- The pathobiology of splicingThe Journal of Pathology, 2009
- Tnni3k Modifies Disease Progression in Murine Models of CardiomyopathyPLOS Genetics, 2009
- Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutationsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- Deletions in CCM2 Are a Common Cause of Cerebral Cavernous MalformationsThe American Journal of Human Genetics, 2007
- Genetics of Cerebral Cavernous AngiomaCentral European Neurosurgery, 2006
- Mutations within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous MalformationsThe American Journal of Human Genetics, 2005
- Tissue-Specific Expression of a Splicing Mutation in the Gene Causes Familial DysautonomiaThe American Journal of Human Genetics, 2001
- Familial Dysautonomia Is Caused by Mutations of the IKAP GeneThe American Journal of Human Genetics, 2001
- Mutations in the Gene Encoding KRIT1, a Krev-1/rap1a Binding Protein, Cause Cerebral Cavernous Malformations (CCM1)Human Molecular Genetics, 1999